MRC1 and neoplasm: Consistent with in vivo data, targeting ISCU also reduced CD206 and Arg1 protein expressions in tumor (Fig. 8N), as well as the presence of CD206+ macrophage infiltrations in TMEs (Supplementary Fig. 5H).